{
    "code": "02025274",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02025274",
    "time": "2020-11-27 07:34:04",
    "許可證字號": "衛署藥輸字第025274號",
    "註銷狀態": "已註銷",
    "註銷日期": "107\/09\/12",
    "註銷理由": "自請註銷",
    "製造許可登錄編號": "",
    "有效日期": "109\/10\/06",
    "發證日期": "99\/10\/06",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202527402",
    "中文品名": "波賽特口服懸液劑",
    "英文品名": "Posanol 40 mg\/ml oral suspension",
    "適應症": "1.\t對amphotericin B或itraconazole或voriconazole治療無效或不能忍受之成人侵入性麴菌病（invasive aspergillosis）的第二線用藥。（無效的定義是先前用有效抗黴菌劑的治療劑量至少7天，感染惡化或未改善）2.\t對itraconazole或fluconazole治療無效或不能忍受之成人口咽念珠菌感染（oropharyngeal candidiasis）的第二線用藥。（無效的定義是先前用有效抗黴菌劑的治療劑量至少治療一段時間：持續性黴菌血症3天，非黴菌血症型感染7天，食道念珠菌病14天，感染惡化或未改善）3.\t適用於13歲以上高危險病人，用來預防侵入性黴菌感染，包括造血幹細胞移植接受者因為植體宿主反應，而接受高劑量免疫抑制劑治療，及acute myelogenous leukemia或高危險myelodysplastic syndrome病人接受誘導化學治療，而引起長期嗜中性白血球減少症。",
    "劑型": "19C口服懸液劑",
    "包裝": "1000毫升以下玻璃瓶裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "POSACONAZOLE, MICRONIZED",
    "限制項目": "58依本署891212衛署藥字第0890035812號公告經本署認定得免除國內銜接性試驗且經本署核定之新藥",
    "申請商名稱": "0929301100  美商默沙東藥廠股份有限公司台灣分公司",
    "申請商地址": "台北市信義區信義路五段106號12樓",
    "主製造廠": [
        {
            "製造廠名稱": "FCA0050000  PATHEON INC.",
            "製造廠廠址": "111 CONSUMERS DRIVE, WHITBY, ONTARIO,L1N 5Z5, CANADA",
            "製造廠公司地址": "",
            "製造廠國別": "CANADA",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "FFR0123000  Cenexi HSC",
            "製造廠廠址": "2, RUE  LOUIS PASTEUR, 14200 HEROUVILLE SAINT CLAIR, FRANCE",
            "製造廠公司地址": "",
            "製造廠國別": "FRANCE",
            "製程": "包裝"
        }
    ],
    "CCC號列": "30042000211 人用醫藥製劑，含抗黴菌劑類抗生素者Medicaments, containing antifungal antibiotics, for human use",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "0812204720",
            "成分名稱": "POSACONAZOLE, MICRONIZED",
            "含量描述": "",
            "含量": "40.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "Posanol Suspension-104-09-23(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025274&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "020252740002-106-06-16.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025274&Seq=008&Type=9"
        },
        {
            "title": "020252740001-106-06-16.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025274&Seq=006&Type=9"
        },
        {
            "title": "02025274-1-106-06-05.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025274&Seq=010&Type=8"
        },
        {
            "title": "02025274-106-06-05.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025274&Seq=009&Type=8"
        }
    ]
}